Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg

GL Pharm Tech Corporation · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
diabetic-neuropathiesdiabetic-neuropathyhealthyneuropathic-painpainfulpharmacokinetics
The purpose of this clinical trial is to (1) evaluate the bioequivalence(BE) of GLA5PR GLARS-NF3 tablet 300mg administered regular diet relative to GLA5PR GLARS-NF1 tablet 300mg administered regular diet and (2) determine the safety and tolerability of a single dose of GLA5PR GLARS-NF3 tablet 300mg administered regular diet and GLA5PR GLARS-NF1 tablet 300mg administered regular diet.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 861949
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive